Immunology
-
Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blocking
This article has 17 authors:Reviewed by ScreenIT
-
Combination of a Sindbis-SARS-CoV-2 Spike Vaccine and αOX40 Antibody Elicits Protective Immunity Against SARS-CoV-2 Induced Disease and Potentiates Long-Term SARS-CoV-2-Specific Humoral and T-Cell Immunity
This article has 9 authors:Reviewed by ScreenIT
-
Structural Basis for SARS-CoV-2 Nucleocapsid Protein Recognition by Single-Domain Antibodies
This article has 3 authors:Reviewed by ScreenIT
-
Accelerated antibody discovery targeting the SARS-CoV-2 spike protein for COVID-19 therapeutic potential
This article has 14 authors:Reviewed by ScreenIT
-
SARS-CoV-2-specific memory B cells can persist in the elderly despite loss of neutralising antibodies
This article has 14 authors:Reviewed by ScreenIT
-
SARS-CoV-2 mRNA Vaccines Elicit Different Responses in Immunologically Naïve and Pre-Immune Humans
This article has 7 authors:Reviewed by ScreenIT
-
SARS coronavirus vaccines protect against different coronaviruses
This article has 9 authors:Reviewed by ScreenIT
-
Metformin Suppresses Monocyte Immunometabolic Activation by SARS-CoV-2 Spike Protein Subunit 1
This article has 5 authors:Reviewed by ScreenIT
-
SARS‐CoV‐2 spike glycoprotein‐reactive T cells can be readily expanded from COVID‐19 vaccinated donors
This article has 6 authors:Reviewed by ScreenIT
-
The legacy of maternal SARS-CoV-2 infection on the immunology of the neonate
This article has 10 authors:Reviewed by ScreenIT